Treatment of severe heart failure dramatically reduced BNP and ANP levels while catecholamines remained elevated, suggesting natriuretic peptides better reflect treatment response.
BNP tracks treatmentBNP and ANP declined with clinical improvement while catecholamines and renin-angiotensin remained activated
What the researchers found
Treatment of acute severe heart failure reduced BNP and ANP levels but not catecholamines or renin-angiotensin activity, indicating natriuretic peptides more accurately reflect clinical improvement.
Why it matters
Knowing which hormones respond to treatment helps clinicians choose the best biomarkers to monitor therapy. The finding that BNP tracks treatment response while catecholamines don't has practical implications for patient monitoring.
How the study worked
Clinical observational study in 9 hospitalized patients with NYHA class IV heart failure. BNP, ANP, neuropeptide Y, catecholamines, and renin system hormones were measured before and after standard treatment.
What this study cannot tell us
Very small sample size (9 patients). Observational design without control group. Treatment was not standardized. Results may not generalize to less severe heart failure.
How to read the evidence
Moderate evidence from a small but well-characterized clinical study measuring multiple biomarkers before and after treatment in severe heart failure.
When this study was published
Published in 1998. Serial BNP monitoring during heart failure treatment is now standard clinical practice.
The bigger picture
Heart failure involves activation of multiple hormonal systems. Understanding that these systems respond differently to treatment helps explain why some patients improve clinically but remain at risk, and guides which biomarkers clinicians should monitor.
Questions still open
- Why do catecholamines remain elevated after clinical improvement?
- Could the persistent renin-angiotensin activation explain the high relapse rate in heart failure?
- Should post-treatment BNP levels guide decisions about discharge timing?
Common questions
Why measure hormones during heart failure treatment?
What does it mean that catecholamines stayed elevated?
Read the original research
How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Clinical science (London, England : 1979), 94(6), 591-9
Citation
Missouris, C G; Grouzmann, E; Buckley, M G; Barron, J; MacGregor, G A; Singer, D R. (1998). How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.. Clinical science (London, England : 1979), 94(6), 591-9.